Business Wire › October 01, 2007
Linked as:Extract
BioLineRx In-Licenses Novel Peptide BL-4050 for the Treatment of Cancer.
JERUSALEM -- BioLineRx Ltd. (TASE:BLRX), Israel's leading drug development company, today announced that it has signed a worldwide exclusive license agree...
See the full content of this document
Sponsored links
ver las páginas en versión mobile | web
ver las páginas en versión mobile | web
© Copyright 2012, vLex. All Rights Reserved.
Contents in vLex United States
Explore vLex
For Professionals
For Partners
Company
Other documents:
carpenters & joiners, local 1620, 94 (1974) | El Conquistador Hotel, Inc., 123 (1970) | f hilgemeier & bro. inc. 352 1962 | New Connecticut Law Regarding Data Security/Destruction And Social Security Numbers | Sentencia nº 6379 de Consiglio di Stato December 21 2009 | Sentencia nº 6771 de Consiglio di Stato December 19 2008 | Decisión de Juzgado Primero de Sustanciación Mediación y Ejecución del Trabajo de Lara Ext... | Decisión nº 1326 de Juzgado del Municipio San Fernando de Apure de Apure, de November 07, 2011
